Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0BS6Q
|
|||
| Former ID |
DNC000570
|
|||
| Drug Name |
Distamycin A
|
|||
| Synonyms |
distamycin a; Stallimycin; Distamycin; Herperetin; 636-47-5; DST-A; UNII-80O63P88IS; NSC82150; FI 6426; CHEMBL11252; 80O63P88IS; NCGC00018292-04; NSC 150528; Stallimycinum; Stallimycine; Estalimicina; Stallimicina; Distamicina A; DISTAMYCIN HYDROCHLORIDE; NSC150528; Dst-3; AC1Q5M1Q; AC1L1F7B; DSSTox_RID_81018; DSSTox_CID_25637; DSSTox_GSID_45637; DISTAMYCIN; STALLIMYCIN; SCHEMBL108585; DTXSID9045637; cid_6602691; UPBAOYRENQEPJO-UHFFFAOYSA-N; ZINC3872327; Tox21_110857; 6576-51-8 (mono-hydrochloride); NSC-82150; CCG-36393; BDBM50055659
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C22H27N9O4
|
|||
| Canonical SMILES |
CN1C=C(C=C1C(=O)NC2=CN(C(=C2)C(=O)NC3=CN(C(=C3)C(=O)NCCC(=N)N)C)C)NC=O
|
|||
| InChI |
1S/C22H27N9O4/c1-29-9-13(26-12-32)6-17(29)21(34)28-15-8-18(31(3)11-15)22(35)27-14-7-16(30(2)10-14)20(33)25-5-4-19(23)24/h6-12H,4-5H2,1-3H3,(H3,23,24)(H,25,33)(H,26,32)(H,27,35)(H,28,34)
|
|||
| InChIKey |
UPBAOYRENQEPJO-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 636-47-5
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
120894, 600885, 7343342, 7887110, 8138425, 8151983, 11446157, 14810114, 26701922, 26707521, 26707530, 26713544, 26713547, 26713659, 26715211, 26718345, 26718346, 26718348, 26718407, 26751619, 29222257, 50101012, 57321617, 79019547, 103171707, 103849789, 103952142, 104171388, 104302564, 117573190, 124634248, 124883617, 124883618, 124883619, 129400152, 134222356, 134339966, 135021566, 135354667, 139066291, 142516461, 144204408, 179226100, 198966165, 223796250, 226482519
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Human Deoxyribonucleic acid minor groove (hDNA min) | Target Info | Binder (minor groove binder) | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Development of distamycin-related DNA binding anticancer drugs. Expert Opin Investig Drugs. 2001 Sep;10(9):1703-14. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.